These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22089527)

  • 1. Fallopian tube correlates of ovarian serous borderline tumors.
    Laury AR; Ning G; Quick CM; Bijron J; Parast MM; Betensky RA; Vargas SO; McKeon FD; Xian W; Nucci MR; Crum CP
    Am J Surg Pathol; 2011 Dec; 35(12):1759-65. PubMed ID: 22089527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.
    Quick CM; Ning G; Bijron J; Laury A; Wei TS; Chen EY; Vargas SO; Betensky RA; McKeon FD; Xian W; Crum CP
    Mod Pathol; 2012 Mar; 25(3):449-55. PubMed ID: 22080059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.
    Chen EY; Mehra K; Mehrad M; Ning G; Miron A; Mutter GL; Monte N; Quade BJ; McKeon FD; Yassin Y; Xian W; Crum CP
    J Pathol; 2010 Sep; 222(1):110-6. PubMed ID: 20597068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.
    Ning G; Bijron JG; Yamamoto Y; Wang X; Howitt BE; Herfs M; Yang E; Hong Y; Cornille M; Wu L; Hanamornroongruang S; McKeon FD; Crum CP; Xian W
    J Pathol; 2014 Dec; 234(4):478-87. PubMed ID: 25130537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.
    Roh MH; Yassin Y; Miron A; Mehra KK; Mehrad M; Monte NM; Mutter GL; Nucci MR; Ning G; Mckeon FD; Hirsch MS; Wa X; Crum CP
    Mod Pathol; 2010 Oct; 23(10):1316-24. PubMed ID: 20562848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
    Tung CS; Mok SC; Tsang YT; Zu Z; Song H; Liu J; Deavers MT; Malpica A; Wolf JK; Lu KH; Gershenson DM; Wong KK
    Mod Pathol; 2009 Sep; 22(9):1243-50. PubMed ID: 19525924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
    Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
    Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital quantification of precursor frequency in the fallopian tube and its significance.
    Bijron JG; Ning G; Laury AR; Quick CM; Betensky RA; Monte NM; King E; McKeon FD; Xian W; Crum CP
    Mod Pathol; 2012 Dec; 25(12):1654-61. PubMed ID: 22766793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.
    Colina JA; Varughese P; Karthikeyan S; Salvi A; Modi DA; Burdette JE
    Carcinogenesis; 2020 Jul; 41(5):646-655. PubMed ID: 31271204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.
    Mehra K; Mehrad M; Ning G; Drapkin R; McKeon FD; Xian W; Crum CP
    Front Biosci (Elite Ed); 2011 Jan; 3(2):625-34. PubMed ID: 21196340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
    Yamamoto Y; Ning G; Howitt BE; Mehra K; Wu L; Wang X; Hong Y; Kern F; Wei TS; Zhang T; Nagarajan N; Basuli D; Torti S; Brewer M; Choolani M; McKeon F; Crum CP; Xian W
    J Pathol; 2016 Mar; 238(4):519-530. PubMed ID: 26415052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
    Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
    Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
    Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M
    Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.
    Singer G; Stöhr R; Cope L; Dehari R; Hartmann A; Cao DF; Wang TL; Kurman RJ; Shih IeM
    Am J Surg Pathol; 2005 Feb; 29(2):218-24. PubMed ID: 15644779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.